Skip to content

A Cohort Study on the Treatment of Subacute Herpetic Neuralgia with Continuous Intrathecal Ropivacaine Infusion

A Cohort Study on the Treatment of Subacute Herpetic Neuralgia with Continuous Intrathecal Ropivacaine Infusion

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500114422
Enrollment
Unknown
Registered
2025-12-11
Start date
2023-07-10
Completion date
Unknown
Last updated
2025-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Herpes zoster

Interventions

Herpes zoster Observation group:None

Sponsors

The Second Xiangya Hospital of Central South University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: From June 2022 to June 2023, in the Pain Department of the Second Xiangya Hospital: 1.Patients with subacute herpes zoster neuralgia have a medical history of more than one month but less than three months. 2. The preoperative total average daily oral lyrica > = 300 mg, digital pain scale (numericalratingscales, NRS) score > = 6 points; 3. The main affected and distributed segments of skin herpes are in the thoracolumbar region. Routine preoperative examinations include blood routine, liver and kidney function, electrolytes, blood glucose, coagulation function, electrocardiogram, chest X-ray, and full-sequence MRI of the head and spine to determine patients without surgical contraindications for intrathecal drug infusion system implantation and who are scheduled to undergo subarachnoid intrathecal infusion for analgesia treatment

Exclusion criteria

Exclusion criteria: 1. Concomitant immunosuppression or an active infectious state. 2. Previous neurolytic block, nerve root radiofrequency ablation, or spinal cord stimulation therapy. 3. Psychiatric or psychological disorders that preclude self-assessment. 4. Coagulation dysfunction or recent use of anticoagulant medications.

Design outcomes

Primary

MeasureTime frame
Pain NRS score;Patterns of postoperative intrathecal drug administration;

Secondary

MeasureTime frame
Sleep assessment scores at 1 and 12 months postoperatively;The overall satisfaction score was evaluated at 1 month and 12 months after operation;Intraoperative and postoperative complications;Basic Information;

Countries

China

Contacts

Public ContactJiang Xinghua

The Second Xiangya Hospital of Central South University

jiangxh@csu.edu.cn+86 731 8529 6145

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026